Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

ANA GARRIDO-CASTRO, MD

Dana-Farber Cancer Institute

Identifying predictive biomarkers of response to PD-1 inhibition in metastatic triple-negative breast cancer

Melanie Hayden Gephart, MD, MAS

Stanford University

Presented by METAvivor Facebook Fundraisers in honor of all people living with MBC

Identification of Race-Specific Tumor-Immune Interactions in Breast-to-Brain Metastases of Black Women

MELANIE HAYDEN GEPHART, MD, MAS

Leland Stanford Junior University

Halting the Progression of Breast Cancer Leptomeningeal Brain Metastases

Antonio Giordano, MD, PhD

Medical University of South Carolina

Presented In Honor of Michael Kovarik by 2019 New York Fashion Week

Phase 1 clinical trial of Polo-like kinase 1 inhibition with nab-paclitaxel in TP53 mutated metastatic triple negative breast ca

TODD GIORGIO, PhD

Vanderbilt University

Quantitative Characterization of Anti-Tumor Immune Response in Metastatic Breast Cancer Induced by Focused Ultrasound

Candece L. Gladson, MD

Cleveland Clinic

FIP200 promotes survival through autophagy of metastatic breast cancer in the brain

ANDREI GOGA, MD, PhD

University of California, San Francisco

Targeting the MYC Pathway in Metastatic Breast Cancer

Ana Gomes, PhD

H. Lee Moffitt Cancer Center & Research Institute

Presented in memory of Molly B. Taylor

Metabolic vulnerabilities of dormant disseminated breast cancer cells

J. CHUCK HARRELL, PhD

Virginia Commonwealth University

Genomic Dissection of Patient-Derived Xenograft Breast Cancer Liver Metastasis Models

MARK HEADLEY, PhD

Fred Hutchinson Cancer Research Center

Monocyte Contribution To Lung Metastasis Of Breast Cancer

Blake “Eason” Hildreth, DVM, MS, PhD

University of Alabama, Birmingham

Targeting the CSF1R/PU.1 axis and PU.1/BET super-enhancer regulome in breast cancer bone metastasis

Daniel Hollern, PhD, BS

The Salk Institute for Biological Studies

Presented by The Orlando Metsquerade in memory of Caitlin Kosma, wife, mother, friend and advocate

Using B cells to eliminate TNBC liver metastases